These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 9440735)

  • 1. Interpreting the significance of changes in health-related quality-of-life scores.
    Osoba D; Rodrigues G; Myles J; Zee B; Pater J
    J Clin Oncol; 1998 Jan; 16(1):139-44. PubMed ID: 9440735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting the Significance of Changes in Health-Related Quality-of-Life Scores.
    Osoba D; Rodrigues G; Myles J; Zee B; Pater J
    J Clin Oncol; 2023 Dec; 41(35):5345-5350. PubMed ID: 38056079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
    Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
    Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy.
    Hong F; Bosco JL; Bush N; Berry DL
    BMC Cancer; 2013 Mar; 13():165. PubMed ID: 23537330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
    Maringwa JT; Quinten C; King M; Ringash J; Osoba D; Coens C; Martinelli F; Vercauteren J; Cleeland CS; Flechtner H; Gotay C; Greimel E; Taphoorn MJ; Reeve BB; Koch JS; Weis J; Smit EF; van Meerbeeck JP; Bottomley A;
    Support Care Cancer; 2011 Nov; 19(11):1753-60. PubMed ID: 20886240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
    Osoba D; Zee B; Pater J; Warr D; Kaizer L; Latreille J
    Qual Life Res; 1994 Oct; 3(5):353-64. PubMed ID: 7841968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting the meaningfulness of changes in health-related quality of life scores: lessons from studies in adults.
    Osoba D
    Int J Cancer Suppl; 1999; 12():132-7. PubMed ID: 10679884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs.
    Snyder CF; Blackford AL; Sussman J; Bainbridge D; Howell D; Seow HY; Carducci MA; Wu AW
    Qual Life Res; 2015 May; 24(5):1207-16. PubMed ID: 25398495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
    Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
    Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in ALTA-1L Trial.
    Beaumont JL; Lin HM; Goodman E; Yu H; Geiger A; Hudgens S
    Value Health; 2024 Feb; 27(2):182-189. PubMed ID: 37951539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.
    Musoro JZ; Bottomley A; Coens C; Eggermont AM; King MT; Cocks K; Sprangers MA; Groenvold M; Velikova G; Flechtner HH; Brandberg Y;
    Eur J Cancer; 2018 Nov; 104():169-181. PubMed ID: 30359910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.
    Bergman B; Sullivan M; Sörenson S
    Acta Oncol; 1992; 31(1):19-28. PubMed ID: 1316770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.
    Chie WC; Yang CH; Hsu C; Yang PC
    Qual Life Res; 2004 Feb; 13(1):257-62. PubMed ID: 15058806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.
    McLachlan SA; Devins GM; Goodwin PJ
    Eur J Cancer; 1998 Mar; 34(4):510-7. PubMed ID: 9713301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer.
    Jang RW; Isogai PK; Mittmann N; Bradbury PA; Shepherd FA; Feld R; Leighl NB
    J Thorac Oncol; 2010 Dec; 5(12):1953-7. PubMed ID: 21155140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13.
    Coon CD; Schlichting M; Zhang X
    Patient; 2022 Nov; 15(6):691-702. PubMed ID: 35771392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
    van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
    Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.